Abstract
Objectives: To assess the applicability of the post ureteroscopy lesion scale (PULS) as an objective measure to define the need for double J (DJ) stent placement after ureterorenoscopy (URS).
Methods: Between June and December 2020 a cross-sectional study was conducted at a university hospital. All patients fulfilling the inclusion criteria undergoing URS for renal or ureteric stones were included. At the completion of procedures, the ureter was carefully inspected for injury. Lesions were classified using PULS scoring by the operating surgeon, another consultant, and the resident. The primary outcome was to validate the PULS score against the surgeon’s decision for postoperative stenting and to assess its reliability.
Results: A total of 126 patients were included with a mean age of 43.42±15.3 years. The mean stone size was 9.42±3.60mm. DJ stents were placed in 81 cases (62.4%). All of the 38 (30.1%) patients with a significant residual fragment were stented. Ureteric injury of grade 1 was observed in 66 patients (52.3%), of which 22 (33%) had DJ stenting. PULS grade 2 injuries were observed in 22 patients (17.4%), and 95% were stented. With a PULS score of > 2 almost all (97.8%) were stented. Inter-rater reliability of PULS scoring was high among the consultants (Kendall’s W=0.89, p<0.005).
Conclusion: DJ stent placement was observed in 33%, 95%, and 98% of patients with PULS grade 1, 2, and >2 injury respectively. In patients with no residual fragment, the need for DJ stenting can be objectively defined using the PULS scoring system as it has high specificity and good interrater reliability.
Keywords: validation, ureteric injury, dj stenting, ureterorenoscopy, puls score
Introduction
Upper tract urolithiasis is a highly prevalent disease worldwide, with rates ranging from 7 to 13% in North America, 5-9% in Europe, and 1-5% in Asia [1]. Stones that fail to pass spontaneously or by assisted medical treatment require an endourological procedure. Double J (DJ) stents are commonly placed for effective drainage of the urinary tract following ureterorenoscopy (URS). DJ stents minimize the risk of postoperative obstruction from edema and promote ureteric healing [2]. However, DJ stents are frequently associated with bothersome side effects and impacts patient quality of life [3]. These stent-related symptoms often require medical treatment with a variable success rate [4]. However, an ideal approach would be to avoid DJ stenting whenever possible. European and American association of urology guidelines also suggest that after uncomplicated ureterorenoscopy DJ stenting can be safely omitted [5]. In the contemporary literature, there is a dearth of clear objective criteria to define uncomplicated ureteroscopy [6]. There are some imperative indications of stenting following ureteroscopy including single kidney, residual stones, impacted stones, ureteral wall edema, and per operative ureteral injury.
One of the ways of defining uncomplicated ureteroscopy is to utilize an objective scoring system like the post ureteroscopy lesion scale (PULS) first reported by Schoenthaler et al. in 2012 [7]. PULS enables standardization of the description of iatrogenic ureteral lesions during ureterorenoscopy and has the potential to objectively define the need for postoperative DJ stenting [8].
DJ stent placement after URS is often required. Post URS ureteric trauma is an important factor in deciding the need for DJ stent placement. In the current practice stenting after URS is a subjective decision. PULS is a standardized way of describing iatrogenic ureteral lesions during URS and can be used to objectively define the need for postoperative DJ stenting.
Materials and methods
Between June 2020 and December 2020, 126 consecutive adult (>18 years) patients undergoing elective ureterorenoscopy (URS) at the Urology Department of a University Hospital were included. Patients with pre-URS stenting, solitary kidney, active infections, or ancillary procedures with URS were excluded. Also patients with a history of ureteric strictures or open surgery requiring DJ stenting were also excluded.
After Aga Khan University Hospital Ethics Review Committee issued approval 2020-4791-10900, data were collected prospectively by chart review for patient demographic details, comorbidities, American Society of Anesthesiology score (ASA), stone-related factors, and pain score on a visual analog scale at the time of discharge. Consultant urologists with experience in at least 50 independent URS performed the procedure. URS was performed either using semi-rigid or rigid ureteroscope or Cobra dual-channel flexible ureterorenoscope (Richard Wolf™) or WiScope® Single-Use Digital Flexible Ureteroscope. Stones were fragmented using pneumatic lithotripter, SWISS lithoclast™ (distal ureteral stones) Holmium-YAG, Lumenis™ 100W, (middle, proximal ureteral and renal stones).
At the completion of the URS the entire length of the ureter was inspected from the pelvi-ureteric junction to the ureteric orifice. Injuries were rated according to the PULS grading system. The operating surgeon, another consultant and the residents were asked to grade the injury independently. Post URS stenting status was recorded and the operating surgeon documented the indication and planned duration of stenting. Patients with residual stones were excluded from the final analysis. Complications were noted on follow-up visits within 30 days. Readmission and ER visits within 30 days were noted from hospital record. Stone clearance was noted on postoperative x-ray, ultrasound, or computed tomography of kidneys, ureters and bladder (CT KUB) at the discretion of the admitting urologist.
Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) version 23 (IBM Corp., Armonk, NY, USA). Continuous variables were described in terms of mean ± SD while qualitative variables were described using frequency and percentages. Multivariate analysis was conducted for factors associated with stenting. Reliability of the tool was reported by Kendall tau statistics by assessing agreement between the two raters. Sensitivity specificity, positive predictive value (PPV), and negative predictive value (NPV) of PULS were calculated by using standard formula considering surgeons' decision as a gold standard. A p-value <0.05 was considered significant throughout the study.
Results
This study included 126 patients who underwent ureterorenoscopy from June to December 2020. Two-thirds (67.46%) were male; the mean age was 43.42±15.3 years. The mean stone size was 9.3±3.60mm. Approximately half (49.2%) of the stones were upper ureteric or renal. Most (81%) of the patients underwent semi-rigid URS. Flexible URS was done in the remaining patients (19%). One in three patients required ureteric dilatation, using reusable metal dilators, and access sheath was used in 21% (Table 1).
Table 1. Patients demographic and stone related characteristics.
| TOTAL (126) | STENTED GROUP 81 | UNSTENTED GROUP 45 | P<0.05 | |
| AGE (years) | 43.42 ± 15.3 | 41.59±14.46 | 46.7± 16.57 | 0.07 |
| GENDER | ||||
| MALE | 85 | 51 | 34 | 0.15 |
| FEMALE | 41 | 30 | 11 | |
| BMI (kg/m2) | 27.1± 4.82 | 27.4± 5.14 | 26.6± 4.21 | 0.37 |
| DIABETES | 32 | 22 | 10 | 0.54 |
| SIDE | ||||
| LEFT | 69 | 43 | 26 | 0.612 |
| RIGHT | 57 | 38 | 19 | |
| STONE PARAMETERS | ||||
| STONE SIZE (mm) | 9.43+3.61 | 10.12+3.39 | 8.20+3.76 | 0.004 |
| SITE (KIDNEY /UPPER URETER) | 61 | 34 | 27 | 0.064 |
| SITE (LOWER/MID URETER) | 65 | 47 | 18 | |
| HYDRONEPHROSIS (mm) | 102 | 70 | 32 | 0.036 |
| PAIN SCORE (VAS) | 2.19+0.92 | 2.23 +0.91 | 2.11+0.96 | 0.47 |
| 30 DAY READMISSION | 3 | 1 | 2 | 0.712 |
DJ stents were placed in 81 cases (64.2%). In most of these cases (47/81) stent was placed for a one- to four-week period. Ureteric injury of grade 1 or less was seen in 99 patients (78.6%) and in 55 of them, a DJ stent was placed. Ureteric injury of grade 2 was observed in 27 patients (21.4%), and all but one of these patients had a DJ stent placed. No grade 3 or above injuries were observed in our series. Thirty-eight patients had residual stones and a DJ stent was placed in all of them and these were excluded from the final analysis for calculation of sensitivity and specificity. Three patients were readmitted within 30 days (two with ureteric colic and one with UTI), and none of the patients had Clavien grade 3 or above complications. Outcome variables like pain score and 30-day readmissions were similar in both groups (Table 1).
A PULS score of ≥ 2 was found to be quite specific (97.8 %) for decision regarding DJ stenting but had low sensitivity (48.8%) (Table 2).
Table 2. Stent placement in various grades of PULS injury scale, with sensitivity, specificity, NPV and PPV of PULS score and stenting.
PULS: post ureteroscopy lesion scale, NPV: negative predictive value, PPV: positive predictive value
| VALUE | 95% CI | ||||
| PULS 0,1 | PULS 2,3 | SENSITIVITY | 48.84% | 33.31% TO 64.54% | |
| UNSTENTED GROUP (N=45) | 44 | 1 | SPECIFICITY | 97.78% | 88.23% TO 99.94% |
| STENTED GROUP (N=43) | 22 | 21 | POSITIVE PREDICTIVE VALUE | 95.45% | 74.70% TO 99.34% |
| NEGATIVE PREDICTIVE VALUE | 66.67% | 59.82% TO 72.88% | |||
| ACCURACY | 73.86% | 63.41% TO 82.66% |
Inter-rater reliability was high both among consultants (Kendall W=0.92; Spearman’s 0.93) and also between residents and the consultant (Kendall’s W =0.89; Spearman’s 0.89) (Figure 1).
Figure 1. Inter observer variability in post ureteroscopy lesion scale score (PULS) between primary operating surgeon, other consultant urological surgeon and the scrubbed resident.
Stone size was significantly larger in patients who had DJ stenting (10.12±3.39 vs. 8.20±3.76; p value=0.004). Moreover patients with hydronephrosis required DJ stenting more frequently (70/81 vs. 32/45; p=0.036). Similarly, patients requiring ureteric dilatation also required DJ stent more frequently (35/81 vs. 7/45; p=0.002). However, on multivariate regression analysis, only stone size and ureteric dilatation were found to be significant predictors of DJ stenting.
Discussion
URS remains the commonest surgical intervention in the management of ureteral stones [9]. Endourological interventions for the treatment of a ureteric stone are often accompanied by the placement of DJ stents. The most frequent indication for ureteric stenting is the drainage of the upper tract and to decrease pain from ureteral wall edema and stone fragmentation following URS.
URS is known to result in some degree of ureteral trauma. Post URS complication rates of 9-11% have been reported, with ureteric perforation accounting for 1-4% [10-14]. Ureteric trauma of varying degrees following URS is an important predictor of DJ stenting. However, indication for post-URS stenting remains largely subjective. European Association of Urology (EAU) and American Urological Association (AUA) guidelines states that it is optional to place an indwelling ureteral stent post uncomplicated ureteroscopy [15,16]. The definition of uncomplicated ureteroscopy too remains subjective. Attempts have been made to assess the use of an injury grading system in helping with this dilemma. We have used the PUL Scale to delineate the degrees of ureteric injury and its applicability for the decision regarding stenting.
Generally the operating surgeon gravitates more towards stenting, resulting in high tendency (63-80%) towards stenting following URS [17,18]. Over 90% of the urologists in a US-based survey were in favor of stenting even after an uncomplicated URS [19]. Stents were placed in most of the cases in our study. Similar findings have been reported in a multi-institutional study, where 65% of the patients had postoperative stenting [20]. Another prospective audit from eight centers in the United Kingdom showed around 74% of patients had some form of ureteric drainage following URS with 68% having stents [18].
Decision to stent or not to stent can be predicted by several patient- and procedural-related factors. The findings of CORES URS Global study suggested the need for an individualized postoperative stenting strategy [21]. Limited insight is available in literature on the factors predicting the necessity of postoperative stenting. Our data highlighted the presence of preoperative hydronephrosis and dilation of the ureteric orifice as the factors associated with increased need for post-URS stenting. This could be explained by the ureteric wall edema resulting from dilatation of the ureter. Boddy et al. reported in an animal study that ureteric edema and upper tract obstruction on imaging lasted for at least 96 hours after ureteric dilation, however there are no equivalent studies in humans [22]. A survey among US-based urologists identified ureteral edema in 77% of the cases as the reason for placement of stents after uncomplicated URS [20]. Postoperative stenting in our study was mainly performed for residual stone, trauma and reasons related to ureteral anatomy i.e. ureteric kink, tight ureter and narrow ureteric orifice.
PULS showed a good specificity for postoperative stenting when compared with the surgeon’s decision but had low sensitivity. After application of the PUL Scale, a grade 0-1 lesion was seen in the majority of our patients. DJ stent was placed even in patients with low-grade injury (≤1PULS) without any residual stones. We feel that the DJ stent could have been safely omitted in these patients.
Considering the adverse effects on the quality of life [23,24], stent placement should ideally be omitted after uncomplicated URS and where required should preferably be kept for the shortest duration necessary. Open-end catheter secured to a Foley catheter overnight is described as a cost-effective measure, obviating stent-related symptoms as well [25]. There is no consensus on the stent indwelling time after URS. Although stent dwell times (more than four weeks) are not beneficial and can even be harmful, it is still to be established whether a shorter stent dwell time can reduce patient morbidity [26]. Nikita et al. reported an ideal duration of dwell time of five days [20]. However, in our practice most of the surgeons preferred to keep stents for one to four weeks.
Our study has certain limitations. It is a single center project, and the analysis does not include all information relevant to postoperative stent placement (stent-related symptoms, stone analysis). Despite these factors, we believe this evidence provides a basis for devising a strategy that is individualized for postoperative stenting in endourology.
Validation of the PULS scoring system will provide clinicians with a tool that can reliably predict the need for Double J stenting and will help clinicians in decision-making and guiding patients about the most appropriate treatment option. After the implementation of PULS-based stenting in clinical practice the number of patients getting unnecessary stenting after uncomplicated URS would be limited. This would be cost-effective as well and the complications associated with stenting would be avoided. Furthermore, audit of postoperative complications including pain score and ER visits after implementation of PULS-based DJ stenting is desirable to validate our results.
Conclusions
DJ stents are frequently placed following URS. Besides residual stones, ureteric trauma is a major reason for placement of DJ stents. In patients without significant residual stones, an objective evaluation of ureteral wall injury provides a rational basis for indicating stents. PULS score shows a high sensitivity and inter-rater reliability and can be easily used for objectively defining uncomplicated ureterorenoscopy and decision for post-URS DJ stenting.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study. Aga Khan University Hospital Ethics Review Committee issued approval 2020-4791-10900
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Epidemiology of stone disease across the world. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. World J Urol. 2017;35:1301–1320. doi: 10.1007/s00345-017-2008-6. [DOI] [PubMed] [Google Scholar]
- 2.Ureteral stenting after uncomplicated ureteroscopy for distal ureteral stones: a randomized, controlled trial. El Harrech Y, Abakka N, El Anzaoui J, Ghoundale O, Touiti D. Minim Invasive Surg. 2014;2014:892890. doi: 10.1155/2014/892890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA. J Endourol. 2007;21:698–702. doi: 10.1089/end.2007.9949. [DOI] [PubMed] [Google Scholar]
- 4.Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial. Nazim SM, Ather MH. J Endourol. 2012;26:1237–1241. doi: 10.1089/end.2012.0036. [DOI] [PubMed] [Google Scholar]
- 5.Guidelines on urolithiasis. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M. Eur Urol. 2001;40:362–371. doi: 10.1159/000049803. [DOI] [PubMed] [Google Scholar]
- 6.Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. Nabi G, Cook J, N'Dow J, McClinton S. BMJ. 2007;334:572. doi: 10.1136/bmj.39119.595081.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Postureteroscopic lesion scale: a new management modified organ injury scale--evaluation in 435 ureteroscopic patients. Schoenthaler M, Wilhelm K, Kuehhas FE, Farin E, Bach C, Buchholz N, Miernik A. J Endourol. 2012;26:1425–1430. doi: 10.1089/end.2012.0227. [DOI] [PubMed] [Google Scholar]
- 8.The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability. Schoenthaler M, Buchholz N, Farin E, et al. World J Urol. 2014;32:1033–1040. doi: 10.1007/s00345-013-1185-1. [DOI] [PubMed] [Google Scholar]
- 9.Advanced ureteroscopy: wireless and sheathless. Johnson GB, Portela D, Grasso M. J Endourol. 2006;20:552–555. doi: 10.1089/end.2006.20.552. [DOI] [PubMed] [Google Scholar]
- 10.Complications of 2735 retrograde semirigid ureteroscopy procedures: a single-center experience. Geavlete P, Georgescu D, Niţă G, Mirciulescu V, Cauni V. J Endourol. 2006;20:179–185. doi: 10.1089/end.2006.20.179. [DOI] [PubMed] [Google Scholar]
- 11.Impact of stone location on success rates of endoscopic lithotripsy for nephrolithiasis. Perlmutter AE, Talug C, Tarry WF, Zaslau S, Mohseni H, Kandzari SJ. Urology. 2008;71:214–217. doi: 10.1016/j.urology.2007.09.023. [DOI] [PubMed] [Google Scholar]
- 12.Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones. Breda A, Ogunyemi O, Leppert JT, Schulam PG. Eur Urol. 2009;55:1190–1196. doi: 10.1016/j.eururo.2008.06.019. [DOI] [PubMed] [Google Scholar]
- 13.Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Bader MJ, Sroka R, Gratzke C, et al. Eur Urol. 2009;56:65–71. doi: 10.1016/j.eururo.2008.12.012. [DOI] [PubMed] [Google Scholar]
- 14.Retrograde intrarenal surgery in treatment of nephrolithiasis: is a 100% stone-free rate achievable? Schoenthaler M, Wilhelm K, Katzenwadel A, Ardelt P, Wetterauer U, Traxer O, Miernik A. J Endourol. 2012;26:489–493. doi: 10.1089/end.2011.0405. [DOI] [PubMed] [Google Scholar]
- 15.EAU guidelines on interventional treatment for urolithiasis. Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. Eur Urol. 2016;69:475–482. doi: 10.1016/j.eururo.2015.07.041. [DOI] [PubMed] [Google Scholar]
- 16.Surgical management of stones: American urological association/endourological society guideline, PART I. Assimos D, Krambeck A, Miller NL, Monga M. https://europepmc.org/article/med/27238616. J Urol. 2016;196:1153–1160. doi: 10.1016/j.juro.2016.05.090. [DOI] [PubMed] [Google Scholar]
- 17.Practice patterns of ureteral stenting after routine ureteroscopic stone surgery: a survey of practicing urologists. Auge BK, Sarvis JA, L'esperance JO, Preminger GM. J Endourol. 2007;21:1287–1291. doi: 10.1089/end.2007.0038. [DOI] [PubMed] [Google Scholar]
- 18.The dilemma of post-ureteroscopy stenting. Hughes B, Wiseman OJ, Thompson T, et al. BJU Int. 2014;113:184–185. doi: 10.1111/bju.12482. [DOI] [PubMed] [Google Scholar]
- 19.Survey on ureTEric draiNage post uncomplicaTed ureteroscopy (STENT) Bhatt NR, MacKenzie K, Shah TT, et al. BJUI Compass. 2021;2:115–125. doi: 10.1002/bco2.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.BAUS Section of Endourology national ureteroscopy audit: setting the standards for revalidation. Mangera A, Parys B. J Clin Urol. 2013;6:45–49. [Google Scholar]
- 21.Risks and benefits of postoperative double-J stent placement after ureteroscopy: results from the Clinical Research Office of Endourological Society ureteroscopy global study. Muslumanoglu AY, Fuglsig S, Frattini A, et al. J Endourol. 2017;31:446–451. doi: 10.1089/end.2016.0827. [DOI] [PubMed] [Google Scholar]
- 22.Acute ureteric dilatation for ureteroscopy. An experimental study. Boddy SA, Nimmon CC, Jones S, Ramsay JW, Britton KE, Levison DA, Whitifield HN. Br J Urol. 1988;61:27–31. doi: 10.1111/j.1464-410x.1988.tb09156.x. [DOI] [PubMed] [Google Scholar]
- 23.Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG. J Urol. 2003;169:1060–1064. doi: 10.1097/01.ju.0000049198.53424.1d. [DOI] [PubMed] [Google Scholar]
- 24.Morbidity and impact on quality of life in patients with indwelling ureteral stents: a 10-year clinical experience. Scarneciu I, Lupu S, Pricop C, Scarneciu C. Pak J Med Sci. 2015;31:522–526. doi: 10.12669/pjms.313.6759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Three techniques for simpler, safer, and cost-effective rigid ureteroscopy. Memon A, Ather MH, Sulaiman MN. https://pubmed.ncbi.nlm.nih.gov/10963492/ Tech Urol. 2000;6:215–217. [PubMed] [Google Scholar]
- 26.How long should double J stent be kept in after ureteroscopic lithotripsy? Shigemura K, Yasufuku T, Yamanaka K, Yamahsita M, Arakawa S, Fujisawa M. Urol Res. 2012;40:373–376. doi: 10.1007/s00240-011-0426-2. [DOI] [PubMed] [Google Scholar]

